Lord, Abbett & Co. LLC Black Diamond Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$22.23 - $34.75 $5.82 Million - $9.1 Million	-261,918 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$29.47 - $35.0 $3.18 Million - $3.78 Million	108,067 Added 70.24%	261,918 $8.39 Million
Q3 2020 Nov 12, 2020	SELL	$26.17 - $43.07 $259,946 - $427,814	-9,933 Reduced 6.06%	153,851 $4.65 Million
Q2 2020 Aug 14, 2020	BUY	$22.3 - $44.8 $580,959 - $1.17 Million	26,052 Added 18.91%	163,784 $6.91 Million
Q1 2020 May 14, 2020	BUY	$18.18 - $39.48 $2.5 Million - $5.44 Million	137,732 New	137,732 $3.44 Million

119

48.1M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $82.5M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.